Gemelli Biotech

Raleigh, United States

Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.

$19.0M raised

Jun 2022

Series A

Biotechnology Health Diagnostics Pharmaceutical

Top Investors

Cedars Sinai Blue Ox Healthcare Partners CerraCap Ventures Carolina Angel Network

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gemelli Biotech

How much funding has Gemelli Biotech raised?

Gemelli Biotech has raised $19.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.

Who are Gemelli Biotech's investors?

Gemelli Biotech's investors include Cedars Sinai, Blue Ox Healthcare Partners, CerraCap Ventures, Carolina Angel Network.

Where is Gemelli Biotech headquartered?

Gemelli Biotech is headquartered in Raleigh, United States.

What does Gemelli Biotech do?

Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.

What stage is Gemelli Biotech at?

Gemelli Biotech is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 22, 2022.

MLA

"Gemelli Biotech — Funding & Investors." VCBacked, June 22, 2022, https://www.vcbacked.co/company/gemelli-biotech. Accessed July 2, 2026.

APA

VCBacked. (2022). Gemelli Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/gemelli-biotech

Wikipedia (cite web)

{{cite web |title=Gemelli Biotech — Funding & Investors |url=https://www.vcbacked.co/company/gemelli-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 22, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K